Granulocyte colony-stimulating factors (G-CSFs) (Filgrastim, Lenograstim, Lipegfilgrastim and Pegfilgrastim) - Important Safety Information from Amgen Europe B.V, Chugai Pharma UK, Teva, Apotex Europe B.V, and Accord Healthcare Ltd as approved by the HPRA

Notice type: 3rd Party Publications

Date: 28/05/2018

Important Safety Information communication from Amgen Europe B.V, Chugai Pharma UK, Teva, Apotex Europe B.V, and Accord Healthcare Ltd - Granulocyte colony-stimulating factors (G-CSFs) (Filgrastim, Lenograstim, Lipegfilgrastim and Pegfilgrastim): New warning regarding aortitis

Important Safety Information - Granulocyte colony-stimulating factors (G-CSFs) (Filgrastim, Lenograstim, Lipegfilgrastim and Pegfilgrastim)